Cellusion CEO Shin Hatou will speak at International Session 3 of the 78th Annual Congress of Japan Clinical Ophthalmology.

■The 78th Annual Congress of Japan Clinical Ophthalmology Date: November 14(Thu.) – 17 (Sun.), 2024
Venue: Kyoto International Conference Center (ICC Kyoto), The Prince Kyoto Takaragaike
Theme: Contribution to the future

■Hatou’s lecture
Thursday, November 14, 15:40-17:00, Room 5
International Session 3
Cornea Clinics Part 2: Surgical therapy -present and future-
Theme: Development of cell therapy for bullous keratopathy using iPS cells